Form 4 for TNON Tenon Medical, Inc.

Accepted 2025-11-18 00:00:00 ET · period of report 2025-11-14 · accession 0001213900-25-112295 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2025-11-18	2025-11-14	TNON	Grawey Nathaniel A.	Chief Commercial Off	P - Purchase	—	+101.2K	239.3K	+73%	—
D	2025-11-18	2025-11-14	TNON	Grawey Nathaniel A.	Chief Commercial Off	P - Purchase	—	+101.2K	101.2K	New	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common stock	2025-11-14	P	A	101,167	—	239,281	D	—	—	(F1) On November 10, 2025, the Issuer entered into a Securities Purchase Agreement for an at-the-market private investment in public equity transaction, in which the reporting person purchased 101,167 shares of common stock of the Issuer and warrants to purchase up to 101,167 shares of common stock of the Issuer. The purchase price for each share of common stock and accompanying warrant was $1.285. The offering closed on November 14, 2025.
2	Derivative	Common Stock Purchase Warrant	2025-11-14	P	A	101,167	—	101,167	D	$1.16 · 2025-11-14 to 2028-11-14	101,167 Common Stock	(F1) On November 10, 2025, the Issuer entered into a Securities Purchase Agreement for an at-the-market private investment in public equity transaction, in which the reporting person purchased 101,167 shares of common stock of the Issuer and warrants to purchase up to 101,167 shares of common stock of the Issuer. The purchase price for each share of common stock and accompanying warrant was $1.285. The offering closed on November 14, 2025.